Reference number : 236-2015-2016-Q1-00343, amendment number : , agreement type : G, recipient legal name : Larche, Mark, recipient country : CA, recipient province : ON, recipient city : Hamilton, recipient postal code : L8N 3Z5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 295386.0, agreement start date : 2015-10-01, agreement end date : 2018-09-30, description english : Development of peptide immunotherapy for Rheumatoid Arthritis: Identification and validation of T cell epitopes from citrullinated auto-antigens., description french : Development of peptide immunotherapy for Rheumatoid Arthritis: Identification and validation of T cell epitopes from citrullinated auto-antigens., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2015-16 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2015-16 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada